You just read:

Arena Pharmaceuticals Presented New Patient-Reported Outcomes Data for Olorinab at the European Society of Neurogastroenterology & Motility NeuroGASTRO 2019 Meeting

News provided by

Arena Pharmaceuticals, Inc.

Sep 09, 2019, 08:30 ET